Lessons from a decade of integrating cancer copy number alterations with gene expression profiles
暂无分享,去创建一个
[1] Renée X. de Menezes,et al. Integrated analysis of DNA copy number and gene expression microarray data using gene sets , 2009, BMC Bioinformatics.
[2] R. Redon,et al. Relative Impact of Nucleotide and Copy Number Variation on Gene Expression Phenotypes , 2007, Science.
[3] Derek Y. Chiang,et al. Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. , 2008, Cancer research.
[4] D. Pe’er,et al. An Integrated Approach to Uncover Drivers of Cancer , 2010, Cell.
[5] I Tomlinson,et al. APC mutations are sufficient for the growth of early colorectal adenomas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[6] H. Varmus,et al. Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[7] Wessel N van Wieringen,et al. Nonparametric Testing for DNA Copy Number Induced Differential mRNA Gene Expression , 2009, Biometrics.
[8] C. Maley,et al. Cancer is a disease of clonal evolution within the body1–3. This has profound clinical implications for neoplastic progression, cancer prevention and cancer therapy. Although the idea of cancer as an evolutionary problem , 2006 .
[9] P. N. Rao,et al. Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification , 2001, Science.
[10] P. Duesberg,et al. Aneuploidy correlated 100% with chemical transformation of Chinese hamster cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[11] Thomas D. Wu,et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.
[12] Cestmir Vlcek,et al. Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers , 2002, Nature Genetics.
[13] W Godolphin,et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.
[14] P. Duesberg,et al. Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[15] D. Albertson,et al. Chromosome aberrations in solid tumors , 2003, Nature Genetics.
[16] B. Ponder,et al. Detailed deletion mapping of chromosome segment 17q12-21 in sporadic breast tumours. , 1994, Genes, chromosomes & cancer.
[17] Michael L. Bittner,et al. Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[18] Philippe Besse,et al. Highlighting relationships between heterogeneous biological data through graphical displays based on regularized canonical correlation analysis , 2009 .
[19] M. Seto,et al. Genome‐wide analysis of DNA copy number alterations and gene expression in gastric cancer , 2008, The Journal of pathology.
[20] M. Ringnér,et al. Segmentation-based detection of allelic imbalance and loss-of-heterozygosity in cancer cells using whole genome SNP arrays , 2008, Genome Biology.
[21] R T Schimke,et al. Gene amplification and drug resistance in cultured murine cells. , 1978, Science.
[22] Trevor Hastie,et al. Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling , 2009, Oncogene.
[23] Wonshik Han,et al. CAMK1D amplification implicated in epithelial–mesenchymal transition in basal‐like breast cancer , 2008, Molecular oncology.
[24] Yuri Kotliarov,et al. Correlation analysis between single-nucleotide polymorphism and expression arrays in gliomas identifies potentially relevant target genes. , 2009, Cancer research.
[25] R. Siebert,et al. Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32) , 2007, Leukemia.
[26] Christian A. Rees,et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[27] Zora Modrusan,et al. Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma , 2007, Proceedings of the National Academy of Sciences.
[28] Pedro Martínez,et al. Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling , 2006, Molecular Cancer.
[29] Wessel N. van Wieringen,et al. CGHregions: Dimension Reduction for Array CGH Data with Minimal Information Loss , 2007 .
[30] D. Conrad,et al. Global variation in copy number in the human genome , 2006, Nature.
[31] P. Duesberg,et al. How aneuploidy affects metabolic control and causes cancer. , 1999, The Biochemical journal.
[32] Paul Medvedev,et al. Computational methods for discovering structural variation with next-generation sequencing , 2009, Nature Methods.
[33] M. A. Wiel,et al. Nonparametric testing for DNA copy number induced differential mRNA gene expression. , 2009 .
[34] J Isola,et al. Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. , 1997, Cancer research.
[35] Jonathan Pevsner,et al. Gene expression alterations over large chromosomal regions in cancers include multiple genes unrelated to malignant progression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[36] S. Goodman,et al. Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. , 2001, Cancer research.
[37] C. Sander,et al. Integrative genomic profiling of human prostate cancer. , 2010, Cancer cell.
[38] Jeroen Beliën,et al. ACE-it: a tool for genome-wide integration of gene dosage and RNA expression data , 2006, Bioinform..
[39] M. Ringnér,et al. Impact of DNA amplification on gene expression patterns in breast cancer. , 2002, Cancer research.
[40] J. A. Berger,et al. Jointly analyzing gene expression and copy number data in breast cancer using data reduction models , 2006, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[41] Charlotte Soneson,et al. Integrative analysis of gene expression and copy number alterations using canonical correlation analysis , 2010, BMC Bioinformatics.
[42] Yi Zhang,et al. Copy number alterations that predict metastatic capability of human breast cancer. , 2009, Cancer research.
[43] Ajay N. Jain,et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. , 2006, Cancer cell.
[44] Joshy George,et al. Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas , 2009, Clinical Cancer Research.
[45] Jun Yao,et al. Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression. , 2006, Cancer research.
[46] D. Pe’er,et al. Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data , 2003, Nature Genetics.
[47] Franck Picard,et al. Preprocessing and downstream analysis of microarray DNA copy number profiles , 2011, Briefings Bioinform..
[48] Robert Tibshirani,et al. DR-Integrator: a new analytic tool for integrating DNA copy number and gene expression data , 2009, Bioinform..
[49] S. Knuutila,et al. Integrated gene copy number and expression microarray analysis of gastric cancer highlights potential target genes , 2008, International journal of cancer.
[50] Eun Sung Park,et al. Identification of potential driver genes in human liver carcinoma by genomewide screening. , 2009, Cancer research.
[51] Joe W. Gray,et al. Magellan: A Web Based System for the Integrated Analysis of Heterogeneous Biological Data and Annotations; Application to DNA Copy Number and Expression Data in Ovarian Cancer , 2006, Cancer informatics.
[52] G. Tseng,et al. Comparison of gene expression and DNA copy number changes in a murine model of lung cancer , 2006, Genes, chromosomes & cancer.
[53] Hyungwon Choi,et al. Global Associations between Copy Number and Transcript mRNA Microarray Data: An Empirical Study , 2008, Cancer informatics.
[54] K. Gunderson,et al. High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping. , 2006, Genome research.
[55] W. Linehan,et al. The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis. , 2001, Cancer research.
[56] Christopher Yau,et al. Comparing CNV detection methods for SNP arrays. , 2009, Briefings in functional genomics & proteomics.
[57] Sampsa Hautaniemi,et al. CNAmet: an R package for integrating copy number, methylation and expression data , 2011, Bioinform..
[58] Calum MacAulay,et al. SIGMA2: A system for the integrative genomic multi-dimensional analysis of cancer genomes, epigenomes, and transcriptomes , 2008, BMC Bioinformatics.
[59] W. Hahn,et al. Derivation of human tumor cells in vitro without widespread genomic instability. , 2001, Cancer research.
[60] M. Wigler,et al. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.
[61] Yidong Chen,et al. High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression. , 2004, Neoplasia.
[62] G R Stark,et al. Gene amplification causes overproduction of the first three enzymes of UMP synthesis in N-(phosphonacetyl)-L-aspartate-resistant hamster cells. , 1979, The Journal of biological chemistry.
[63] K. Kinzler,et al. The Genetic Basis of Human Cancer , 1997 .
[64] Brian H. Dunford-Shore,et al. Somatic mutations affect key pathways in lung adenocarcinoma , 2008, Nature.
[65] L. Chin,et al. High-resolution genomic profiles of human lung cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[66] M. Marra,et al. Applications of next-generation sequencing technologies in functional genomics. , 2008, Genomics.
[67] Adam B. Olshen,et al. Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis , 2009, Bioinform..
[68] Martin Schäfer,et al. Integrated analysis of copy number alterations and gene expression: a bivariate assessment of equally directed abnormalities , 2009, Bioinform..
[69] D. Pinkel,et al. Array comparative genomic hybridization and its applications in cancer , 2005, Nature Genetics.
[70] O. Kallioniemi,et al. Identification of target genes in laryngeal squamous cell carcinoma by high-resolution copy number and gene expression microarray analyses , 2006, Oncogene.
[71] S. Rafii,et al. Splitting vessels: Keeping lymph apart from blood , 2003, Nature Medicine.
[72] Peter J. Park,et al. Integrative analysis reveals the direct and indirect interactions between DNA copy number aberrations and gene expression changes , 2008, Bioinform..
[73] Jean Marx,et al. Debate Surges Over the Origins of Genomic Defects in Cancer , 2002, Science.
[74] T. P. Dryja,et al. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma , 1983, Nature.
[75] Li-Xuan Qin,et al. An Integrative Analysis of microRNA and mRNA Expression—A Case Study , 2008, Cancer informatics.
[76] Sylvia Richardson,et al. Detection of gene copy number changes in CGH microarrays using a spatially correlated mixture model , 2006, Bioinform..
[77] Roberta Spinelli,et al. A computational procedure to identify significant overlap of differentially expressed and genomic imbalanced regions in cancer datasets† , 2009, Nucleic acids research.
[78] Nallasivam Palanisamy,et al. Targets of genome copy number reduction in primary breast cancers identified by integrative genomics , 2007, Genes, chromosomes & cancer.
[79] B. Vogelstein,et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. , 1990, Cancer research.
[80] R. Weinberg,et al. Function of a human cyclin gene as an oncogene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[81] Dimitri Semizarov,et al. Integrative Genomic Analysis of Small-Cell Lung Carcinoma Reveals Correlates of Sensitivity to Bcl-2 Antagonists and Uncovers Novel Chromosomal Gains , 2007, Molecular Cancer Research.
[82] G. Hannon,et al. Deletion of the p16 and p15 genes in human bladder tumors. , 1995, Journal of the National Cancer Institute.
[83] Francesco Bertoni,et al. Genomic and expression profiling identifies the B‐cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma , 2006, British journal of haematology.
[84] Zohar Yakhini,et al. Joint Analysis of DNA Copy Numbers and Gene Expression Levels , 2004, WABI.
[85] P. Duesberg,et al. Are cancers dependent on oncogenes or on aneuploidy? , 2003, Cancer genetics and cytogenetics.
[86] Howard Y. Chang,et al. Genetic regulators of large-scale transcriptional signatures in cancer , 2006, Nature Genetics.
[87] T. Golub,et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma , 2005, Nature.
[88] Ji Zhu,et al. Regularized Multivariate Regression for Identifying Master Predictors with Application to Integrative Genomics Study of Breast Cancer. , 2008, The annals of applied statistics.
[89] Ash A. Alizadeh,et al. Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds , 2004, PLoS biology.
[90] J. Uhm. An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2009 .